Answers are grounded in this paper and cite their sources.
Objective To evaluate the effects of multiple-dose oral metoclopramide administration on food intake, fecal output, and body weight in healthy rabbits with experimentally induced hyporexia. Methods Two pilot studies were performed to inform the methods of the main study. In the main study, twelve 3-month-old intact (6 male and 6 females; body weight, 2.6 ± 0.17 kg) New Zealand white rabbits ( Oryctolagus cuniculus ) were used in a randomized, blinded, placebo-controlled complete crossover study. Hyporexia was successfully induced in 11 of 12 rabbits by administering high-concentration buprenorphine (0.24 mg/kg) SC every 24 hours for 2 days. Following induction of hyporexia, rabbits (n = 11) were administered metoclopramide (5 mg/kg) orally every 12 hours for 2 days based upon pilot study results. Fecal output, food intake, and body weight were measured daily before, during, and after treatment to assess the effects of metoclopramide on these parameters. Results Administration of high-concentration buprenorphine produced a significant decrease in food intake and fecal output compared to baseline in both the metoclopramide and control treatments. There was no significant difference in food intake or fecal output over time between the metoclopramide and control treatments. Conclusions Oral administration of metoclopramide at 5 mg/kg every 12 hours for 2 days had no clinically relevant or statistically significant effect on food intake or fecal output in healthy rabbits with experimentally induced hyporexia. Clinical Relevance Current knowledge regarding the efficacy of metoclopramide in hyporexic rabbits does not support its routine use in clinical situations.
No takes yet. Share an insight, caveat, or question.
Stratton et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: